Clinical Trial Update: Development of a New HIV Vaccine [Phase 1]

View source ↗

Summary

Completion of a Phase 1 clinical trial evaluating a new HIV vaccine sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED